Goehring & Rozencwajg Associates’s Nutrien NTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$91.6M Buy
1,455,019
+632,728
+77% +$44.2M 5.27% 8
2026
Q1
$62.1M Sell
822,291
-3,146
-0.4% -$224K 3.33% 12
2025
Q4
$50.9M Buy
825,437
+45,199
+6% +$2.66M 5.05% 6
2025
Q3
$45.8M Sell
780,238
-836
-0.1% -$48.7K 5.51% 5
2025
Q2
$45.5M Buy
781,074
+109,245
+16% +$6.17M 6.96% 3
2025
Q1
$35.2M Buy
671,829
+471,390
+235% +$24.1M 6.39% 2
2024
Q4
$9M Sell
200,439
-11,858
-6% -$563K 1.85% 23
2024
Q3
$10.2M Buy
212,297
+9,114
+4% +$439K 2.08% 19
2024
Q2
$10.3M Buy
203,183
+17,500
+9% +$958K 2.05% 17
2024
Q1
$10.1M Buy
185,683
+6,420
+4% +$335K 2.18% 14
2023
Q4
$10.1M Buy
179,263
+75,437
+73% +$4.26M 2.44% 12
2023
Q3
$6.41M Sell
103,826
-65,727
-39% -$4.16M 1.57% 27
2023
Q2
$10M Buy
169,553
+39,043
+30% +$2.49M 2.88% 11
2023
Q1
$9.64M Buy
130,510
+6,038
+5% +$466K 3.29% 9
2022
Q4
$9.09M Buy
+124,472
New +$9.83M 3.23% 9

Other funds holding NTR

Goehring & Rozencwajg Associates's NTR Position: Q2 2026 in Review

Goehring & Rozencwajg Associates increased its Nutrien (NTR) stake by 77% in Q2 2026, buying an estimated $44.2M and bringing the position to 1,455,019 shares worth $91.6M. The position accounts for 5.27% of the portfolio, ranked #8.

Goehring & Rozencwajg Associates first reported a position in NTR in Q4 2022 and has held it in 15 quarters since. 732 funds tracked by Wall St. Rank hold NTR as of Q2 2026.

  • Goehring & Rozencwajg Associates held 1,455,019 shares of Nutrien worth $91.6M as of Q2 2026.
  • Goehring & Rozencwajg Associates bought 632,728 Nutrien shares in Q2 2026, an estimated $44.2M.
  • Nutrien made up 5.27% of Goehring & Rozencwajg Associates's portfolio in Q2 2026, its #8 holding.
  • Goehring & Rozencwajg Associates first reported a position in Nutrien in Q4 2022 and has held it in 15 quarters since.
  • 732 funds tracked by Wall St. Rank held Nutrien as of Q2 2026.

Based on Goehring & Rozencwajg Associates's 13F filing for Q2 2026, filed 5 Aug 2026.